PHBBF.US Pharmaron Beijing Co., Ltd.

Healthcare Biotechnology USA Stocks
9.85 USD
Close of Nov 16, 2026
1.90 1.93
Market cap
USD 3.55B
P/E
16.1x
P/B
1.98x
ROE
9.8%
Dividend yield
1.43%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PHBBF.US undervalued?

Graham number
Price9.85
Graham value8.28
Premium18.9%

PHBBF.US trades 18.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmaron Beijing Co., Ltd. fundamental analysis

No fundamental analysis for Pharmaron Beijing Co., Ltd. yet.

Pharmaron Beijing Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological …

Full company profile